Companies Dominating the Sepsis Diagnostics Landscape
- BioMérieux SA
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Becton, Dickinson and Company
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche AG
- Danaher Corporation (Beckman Coulter, Inc.)
- Cepheid
- Beckman Coulter, Inc.
- Amara Health Analytics
- Wolters Kluwer N.V.
- Cerner Corp.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Currently in 2025, the industry revenue of sepsis diagnostics is evaluated at USD 2.71 billion.
The global sepsis diagnostics market is set to rise from USD 2.5 billion in 2024 to USD 10.91 billion by 2037, demonstrating a CAGR of more than 12% throughout the forecast period, from 2025 to 2037.
North America industry is likely to dominate majority revenue share of 39% by 2037, due to increasing and developed healthcare infrastructure in the region.
The major players in the market include BioMérieux SA, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, Danaher Corporation (Beckman Coulter, Inc.), Cepheid, Beckman Coulter, Inc., Amara Health Analytics, Wolters Kluwer N.V., Cerner Corp.
